Eight prostate cancer patients undergoing radiation treatment were scanned on an MR-Linac with conventional ADC and high-b diffusion protocols at each of five treatment fractions. With the system’s weaker gradients and longer echo times, 6/8 patients had visible lesions at the maximum b-value of 2000 s/mm2. Fits to the VERDICT model demonstrated higher intracellular fraction in the lesion, inversely correlated with ADC. In three patients, ADC increased starting at the third treatment time point; a fourth patient exhibited a transient ADC increase. Future work will correlate these changes with biochemical recurrence to test their relevance as a biomarker.
This abstract and the presentation materials are available to members only; a login is required.